276 related articles for article (PubMed ID: 3438083)
1. Fragile sites are targets of diverse mutagens and carcinogens.
Yunis JJ; Soreng AL; Bowe AE
Oncogene; 1987 Mar; 1(1):59-69. PubMed ID: 3438083
[TBL] [Abstract][Full Text] [Related]
2. Correlation of fragile sites and bleomycin induced chromosome break points.
Murthy SK; Patel JK; Krishnamurthy DS
Indian J Exp Biol; 1989 May; 27(5):442-4. PubMed ID: 2480936
[TBL] [Abstract][Full Text] [Related]
3. [Significance of inherited fragile sites in the occurrence of chromosome aberrations in tumor cells].
S'iakste TG; Erenpreĭs IaG
Tsitol Genet; 1987; 21(4):306-10. PubMed ID: 3314050
[TBL] [Abstract][Full Text] [Related]
4. Nuclear enzymes, fragile sites, and cancer.
Yunis JJ; Hoffman WR
J Gerontol; 1989 Nov; 44(6):37-44. PubMed ID: 2553792
[TBL] [Abstract][Full Text] [Related]
5. [Fragile sites on human chromosomes and cancer-specific chromosomal rearrangements].
Hori T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):667-76. PubMed ID: 3963838
[TBL] [Abstract][Full Text] [Related]
6. Common fragile sites.
Glover TW
Cancer Lett; 2006 Jan; 232(1):4-12. PubMed ID: 16229941
[TBL] [Abstract][Full Text] [Related]
7. Characterization of FRA7B, a human common fragile site mapped at the 7p chromosome terminal region.
Bosco N; Pelliccia F; Rocchi A
Cancer Genet Cytogenet; 2010 Oct; 202(1):47-52. PubMed ID: 20804921
[TBL] [Abstract][Full Text] [Related]
8. [Chromosome fragile sites in patients with multiple primary tumors and familial forms of breast cancer].
Kuleshov NP; Cortina-Guerrero GD; Razinkova GA; Gar'kavtseva RF; Nefedov MD; Kuzina NIu; Letiagin VP
Vopr Onkol; 1992; 38(2):160-6. PubMed ID: 1300700
[TBL] [Abstract][Full Text] [Related]
9. [Fragile sites of cultured peripheral blood lymphocyte chromosomes in patients with gestational trophoblastic tumor].
Xu C
Zhonghua Fu Chan Ke Za Zhi; 1990 May; 25(3):159-61, 189. PubMed ID: 2167825
[TBL] [Abstract][Full Text] [Related]
10. [Expression of new fragile sites detected in lymphoproliferative processes].
Fundia AF; Slavutsky IR; Larripa IB
Sangre (Barc); 1990 Feb; 35(1):4-9. PubMed ID: 2139745
[TBL] [Abstract][Full Text] [Related]
11. Fragile sites and chromosomal structural rearrangements in human leukemia and cancer.
de Braekeleer M
Anticancer Res; 1987; 7(3 Pt B):417-22. PubMed ID: 3631895
[TBL] [Abstract][Full Text] [Related]
12. Fragile sites and spontaneous abortions.
Toncheva D
Genet Couns; 1991; 2(4):205-10. PubMed ID: 1799417
[TBL] [Abstract][Full Text] [Related]
13. [Induction of fragile sites by chemical and physical agents].
Fundia AF; Larripa IB
Acta Physiol Pharmacol Ther Latinoam; 1991; 41(3):359-67. PubMed ID: 1843869
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis of common and rare fragile sites.
Schwartz M; Zlotorynski E; Kerem B
Cancer Lett; 2006 Jan; 232(1):13-26. PubMed ID: 16236432
[TBL] [Abstract][Full Text] [Related]
15. Relationship between chemical-induced fragile sites and chromosomal breakpoints in malignant cells in children.
Ribeiro RC; Douglass EC; Williams DL; Raimondi SC; Valentine M; Lewis S; Crist WM
Leuk Lymphoma; 1992 Aug; 7(5-6):401-7. PubMed ID: 1493441
[TBL] [Abstract][Full Text] [Related]
16. Deletions in chromosome 2 and fragile sites.
Palmer CG; Heerema N; Bull M
Am J Med Genet; 1990 Jun; 36(2):214-8. PubMed ID: 2368809
[TBL] [Abstract][Full Text] [Related]
17. Expression of aphidicolin-induced fragile sites and their relationship between genetic susceptibility in breast cancer, ovarian cancer, and non-small-cell lung cancer patients.
Dhillon VS; Husain SA; Ray GN
Teratog Carcinog Mutagen; 2003; Suppl 1():35-45. PubMed ID: 12616595
[TBL] [Abstract][Full Text] [Related]
18. Common fragile sites and cancer: targeted cloning by insertional mutagenesis.
Büttel I; Fechter A; Schwab M
Ann N Y Acad Sci; 2004 Dec; 1028():14-27. PubMed ID: 15650228
[TBL] [Abstract][Full Text] [Related]
19. [Genetic etiology of esophageal cancer. V. Fragile sites on chromosome of cultured lymphocytes from members of high risk cancer families in Linxian County].
Wu YQ
Zhonghua Zhong Liu Za Zhi; 1990 May; 12(3):174-8. PubMed ID: 2249587
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of chromosome fragile site 10q25 in chronic myelogenous leukemia.
Morgan R; Morgan SS; Hecht F
Am J Med Genet; 1985 Jun; 21(2):347-50. PubMed ID: 3860008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
